New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 3, 2014
11:11 EDTMYGN, LH, ILMN, DGX, GHDX, QGENPiper sees ASCO positive for Myriad, Genomic, Illumina at Piper Jaffray
Piper Jaffray said it views the American Society of Clinical Oncology conference as positive for Myriad Genetics (MYGN), Genomic Health (GHDX) and Illumina (ILMN), neutral for QIAGEN (QGEN), and neutral-to-negative for Quest Diagnostics (DGX) and LabCorp (LH). Piper notes traffic for Quest and LabCorp booths was lower than Myriad, which it called the "clear winner" among the BRCA test providers.
News For MYGN;GHDX;ILMN;QGEN;DGX;LH From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
April 27, 2015
06:49 EDTLHLabCorp: Q1 earnings reduced by restructuring and special items of $191.3M
As a result, the company recognized net earnings in the quarter of $700K, or 1c per diluted share, compared to $113.1 million, or $1.31 per diluted share, last year.
06:48 EDTLHLabCorp raises FY15 adjusted EPS to $7.55-$7.90 from $7.35-$7.70
Subscribe for More Information
06:45 EDTLHLabCorp reports Q1 adjusted EPS $1.73, consensus $1.63
Subscribe for More Information
April 23, 2015
10:03 EDTILMNIllumina upgraded to Strong Buy from Buy at Tigress Financial
Subscribe for More Information
07:08 EDTDGXQuest Diagnostics backs FY15 adjusted EPS view $4.70-$4.85, consensus $4.78
Subscribe for More Information
07:06 EDTDGXQuest Diagnostics reports Q1 adjusted EPS $1.05, consensus $1.04
Subscribe for More Information
April 22, 2015
15:50 EDTDGXNotable companies reporting before tomorrow's open
Subscribe for More Information
14:11 EDTILMNIllumina falls after results, price target bumps
Subscribe for More Information
13:30 EDTILMNIllumina weakness a buying opportunity, says Cowen
Subscribe for More Information
06:40 EDTILMNIllumina price target raised to $240 from $215 at Citigroup
Subscribe for More Information
06:05 EDTILMNIllumina price target raised to $230 from $220 at Mizuho
Subscribe for More Information
April 21, 2015
19:06 EDTILMNOn The Fly: After Hours Movers
Subscribe for More Information
16:13 EDTILMNIllumina raises FY15 adjusted EPS view to $3.36-$3.42 from $3.12-$3.18
Subscribe for More Information
16:12 EDTILMNIllumina reports Q1 gross margin 69.6% vs. 66.1% in prior year period
Subscribe for More Information
16:11 EDTILMNIllumina reports Q1 adjusted EPS 91c, consensus 72c
Subscribe for More Information
15:28 EDTILMNNotable companies reporting after market close
Subscribe for More Information
08:14 EDTLH, DGXQuest Diagnostics and Inserm launch BRCA Share initiative
Quest Diagnostics (DGX) and Inserm, the French National Institute of Health and Medical Research institution, launched BRCA Share, a novel datashare initiative they co-founded to provide scientists and laboratory organizations around the world with open access to BRCA1 and BRCA2 genetic data. The program's goal is to accelerate research on BRCA gene mutations, particularly variants of uncertain significance, to improve the ability of clinical laboratory diagnostics to predict which individuals are at risk of developing hereditary breast and ovarian cancers. Laboratory Corporation of America Holdings (LH) is the first participant in the initiative, which is structured as a user group. B
06:40 EDTLH, MYGN, DGXStart-up to offer saliva test for breast cancer susceptibility, NY Times says
Subscribe for More Information
April 20, 2015
13:28 EDTILMNIllumina May volatility elevated into Q1 and outlook
Illumina April call option implied volatility is at 89, May is at 48, June is at 34, September at 48; compared to its 26-week average of 37 according to Track Data, suggesting larger near term price movement into the expected release of Q1 results on April 21.
April 15, 2015
12:32 EDTDGXFocus Diagnostics announced FDA clearance for Simplexa Group A Strep Direct Kit
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use